Literature DB >> 17036776

Motion preservation technologies: alternatives to spinal fusion.

Kern Singh1, Howard S An.   

Abstract

Spinal arthrodesis is a versatile and effective option in the management of instabilities, deformities, and painful spinal conditions. An increasing body of biomechanical and clinical evidence suggests that the relative immobility of fused spinal segments alters stress transfer, leading to adjacent-level degeneration. The development of nonfusion spinal prostheses has been driven by increasing concerns regarding these arthrodesis-related morbidities, including graft-site harvest, pseudarthrosis, and adjacent-level degeneration. Motion-sparing implants offer some theoretical advantages over fusion; however, judicious use of these products with careful patient selection is warranted until outcome studies can demonstrate their efficacy. In this article, we review the 3 major categories of nonfusion technologies: total disc replacement, prosthetic nuclear implants, and posterior stabilization devices.

Entities:  

Mesh:

Year:  2006        PMID: 17036776

Source DB:  PubMed          Journal:  Am J Orthop (Belle Mead NJ)        ISSN: 1078-4519


  3 in total

1.  Biomechanical evaluation of the Total Facet Arthroplasty System® (TFAS®): loading as compared to a rigid posterior instrumentation system.

Authors:  Simon G Sjovold; Qingan Zhu; Anton Bowden; Chad R Larson; Peter M de Bakker; Marta L Villarraga; Jorge A Ochoa; David M Rosler; Peter A Cripton
Journal:  Eur Spine J       Date:  2012-03-10       Impact factor: 3.134

2.  Does Wallis implant reduce adjacent segment degeneration above lumbosacral instrumented fusion?

Authors:  Panagiotis Korovessis; Thomas Repantis; Spyros Zacharatos; Andreas Zafiropoulos
Journal:  Eur Spine J       Date:  2009-04-23       Impact factor: 3.134

3.  Update on cervical disc arthroplasty: where are we and where are we going?

Authors:  Jorge J Jaramillo-de la Torre; Jonathan N Grauer; James J Yue
Journal:  Curr Rev Musculoskelet Med       Date:  2008-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.